<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Heparin-induced thrombocytopenia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Heparin-induced_thrombocytopenia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Heparin-induced_thrombocytopenia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Heparin-induced_thrombocytopenia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Heparin-induced_thrombocytopenia","wgTitle":"Heparin-induced thrombocytopenia","wgCurRevisionId":667652470,"wgRevisionId":667652470,"wgArticleId":1056911,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with contributors link","All articles with unsourced statements","Articles with unsourced statements from February 2013","Good articles","Articles that use a Medicine navs subtemplate","Coagulopathies"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Heparin-induced_thrombocytopenia","wgRelevantArticleId":1056911,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Heparin-induced_thrombopenia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/e/ef/PBB_Protein_PF4_image.jpg/100px-PBB_Protein_PF4_image.jpg","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Heparin-induced_thrombocytopenia","wgWikibaseItemId":"Q1598365"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Heparin-induced_thrombocytopenia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
<div id="mw-indicator-good-star" class="mw-indicator"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/19px-Symbol_support_vote.svg.png" width="19" height="20" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/29px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/39px-Symbol_support_vote.svg.png 2x" data-file-width="180" data-file-height="185" /></a></div>
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Heparin-induced thrombocytopenia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Heparin-induced_thrombopenia&amp;redirect=no" title="Heparin-induced thrombopenia">Heparin-induced thrombopenia</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Heparin-induced thrombocytopenia</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:PBB_Protein_PF4_image.jpg" class="image"><img alt="PBB Protein PF4 image.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ef/PBB_Protein_PF4_image.jpg/230px-PBB_Protein_PF4_image.jpg" width="230" height="230" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ef/PBB_Protein_PF4_image.jpg/345px-PBB_Protein_PF4_image.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ef/PBB_Protein_PF4_image.jpg/460px-PBB_Protein_PF4_image.jpg 2x" data-file-width="500" data-file-height="500" /></a>
<div>A schematic drawing of platelet factor 4, which when bound to heparin leads to an immune response in HIT.</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/D69.5">D69.5</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=289.84">289.84</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000556.htm">000556</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/1357846-overview">article/1357846</a></td>
</tr>
</table>
<p><b>Heparin-induced thrombocytopenia</b> (<b>HIT</b>) is the development of <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a> (a low <a href="/wiki/Platelet" title="Platelet">platelet</a> count), due to the administration of various forms of <a href="/wiki/Heparin" title="Heparin">heparin</a>, an <a href="/wiki/Anticoagulant" title="Anticoagulant">anticoagulant</a>. HIT predisposes to <a href="/wiki/Thrombosis" title="Thrombosis">thrombosis</a>, the abnormal formation of blood clots inside a <a href="/wiki/Blood_vessel" title="Blood vessel">blood vessel</a>, and when thrombosis is identified the condition is called <b>heparin-induced thrombocytopenia and thrombosis</b> (<b>HITT</b>). HIT is caused by the formation of abnormal <a href="/wiki/Antibody" title="Antibody">antibodies</a> that activate platelets. If someone receiving heparin develops new or worsening thrombosis, or if the platelet count falls, HIT can be confirmed with specific <a href="/wiki/Blood_test" title="Blood test">blood tests</a>.<sup id="cite_ref-Ahmed_1-0" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup></p>
<p>The treatment of HIT requires both protection from thrombosis and choice of an agent that will not reduce the platelet count further. Several agents exist for this purpose, mainly <a href="/wiki/Lepirudin" title="Lepirudin">lepirudin</a> and <a href="/wiki/Argatroban" title="Argatroban">argatroban</a>.<sup id="cite_ref-Ahmed_1-1" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup> While heparin was discovered in the 1930s, HIT was not reported until the 1960s and 1970s.<sup id="cite_ref-KeltonWarkentin_2-0" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Mechanism"><span class="tocnumber">2</span> <span class="toctext">Mechanism</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Treatment"><span class="tocnumber">4</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Epidemiology"><span class="tocnumber">5</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#History"><span class="tocnumber">6</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Heparin may be used for both prevention and the treatment of thrombosis. It exists in two main forms: an "unfractionated" form that can be <a href="/wiki/Subcutaneous_injection" title="Subcutaneous injection">injected under the skin</a> or through an <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">intravenous infusion</a>, and a "low molecular weight" form that is generally given <a href="/wiki/Subcutaneous_injection" title="Subcutaneous injection">subcutaneously</a> (administered under the skin). Commonly used low molecular weight heparins are <a href="/wiki/Enoxaparin" title="Enoxaparin" class="mw-redirect">enoxaparin</a>, <a href="/wiki/Dalteparin" title="Dalteparin" class="mw-redirect">dalteparin</a>, and <a href="/wiki/Tinzaparin" title="Tinzaparin" class="mw-redirect">tinzaparin</a>.<sup id="cite_ref-Hirsh_3-0" class="reference"><a href="#cite_note-Hirsh-3"><span>[</span>3<span>]</span></a></sup></p>
<p>In HIT, the platelet count in the blood falls below the normal range, a condition called <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a>. However, it is generally not low enough to lead to an increased risk of bleeding. Most people with HIT will therefore not experience any symptoms. Typically the platelet count will fall 5–14 days after heparin is first given; if someone has received heparin in the previous three months, the fall in platelet count may occur sooner, sometimes within a day.<sup id="cite_ref-Ahmed_1-2" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup></p>
<p>The most common symptom of HIT is enlargement or extension of a previously diagnosed blood clot, or the development of a new blood clot elsewhere in the body. This may take the form of clots either in <a href="/wiki/Artery" title="Artery">arteries</a> or <a href="/wiki/Vein" title="Vein">veins</a>, causing arterial or venous thrombosis, respectively. Examples of arterial thrombosis are <a href="/wiki/Stroke" title="Stroke">stroke</a>, <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> ("heart attack"), and <a href="/wiki/Peripheral_vascular_disease" title="Peripheral vascular disease" class="mw-redirect">acute leg ischemia</a>. Venous thrombosis may occur in the leg or arm in the form of <a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">deep vein thrombosis</a> (DVT) and in the <a href="/wiki/Lung" title="Lung">lung</a> in the form of a <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a> (PE); the latter usually originate in the leg but migrate to the lung.<sup id="cite_ref-Ahmed_1-3" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Warkentin2006_4-0" class="reference"><a href="#cite_note-Warkentin2006-4"><span>[</span>4<span>]</span></a></sup></p>
<p>In those receiving heparin through an intravenous infusion, a complex of symptoms ("systemic reaction") may occur when the infusion is started. These include <a href="/wiki/Fever" title="Fever">fever</a>, <a href="/wiki/Rigor_(medicine)" title="Rigor (medicine)" class="mw-redirect">chills</a>, <a href="/wiki/Hypertension" title="Hypertension">high blood pressure</a>, <a href="/wiki/Tachycardia" title="Tachycardia">a fast heart rate</a>, <a href="/wiki/Dyspnea" title="Dyspnea">shortness of breath</a>, and <a href="/wiki/Chest_pain" title="Chest pain">chest pain</a>. This happens in about a quarter of people with HIT. Others may develop a skin rash consisting of <a href="/wiki/Erythema" title="Erythema">red spots</a>.<sup id="cite_ref-Ahmed_1-4" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Warkentin2006_4-1" class="reference"><a href="#cite_note-Warkentin2006-4"><span>[</span>4<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Mechanism">Mechanism</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit&amp;section=2" title="Edit section: Mechanism">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Heparin occurs naturally in the human body, but the development of HIT antibodies suggests heparin may act as a <a href="/wiki/Hapten" title="Hapten">hapten</a>, and thus be targeted by the <a href="/wiki/Immune_system" title="Immune system">immune system</a>. In HIT, the immune system forms <a href="/wiki/Antibody" title="Antibody">antibodies</a> against heparin when it is bound to a protein called <a href="/wiki/Platelet_factor_4" title="Platelet factor 4">platelet factor 4</a> (PF4). These antibodies are usually of the <a href="/wiki/Immunoglobulin_G" title="Immunoglobulin G">IgG</a> class and their development usually takes about five days. However, those who have been exposed to heparin in the last few months may still have circulating IgG, as IgG-type antibodies generally continue to be produced even when their precipitant has been removed. This is similar to <a href="/wiki/Immunity_(medical)" title="Immunity (medical)">immunity</a> against certain microorganisms, with the difference that the HIT antibody does not persist more than three months.<sup id="cite_ref-Ahmed_1-5" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Warkentin2006_4-2" class="reference"><a href="#cite_note-Warkentin2006-4"><span>[</span>4<span>]</span></a></sup> HIT antibodies have been found in individuals with thrombocytopenia and thrombosis who had no prior exposure to heparin, but the majority are found in people who are receiving heparin.<sup id="cite_ref-WarkentinMakris_5-0" class="reference"><a href="#cite_note-WarkentinMakris-5"><span>[</span>5<span>]</span></a></sup></p>
<p>The IgG antibodies form a complex with heparin and PF4 in the bloodstream. The tail of the antibody then binds to the <a href="/wiki/FCGR2A" title="FCGR2A">FcγIIa receptor</a>, a protein on the surface of the platelet. This results in platelet activation and the formation of platelet microparticles, which initiate the formation of blood clots; the platelet count falls as a result, leading to thrombocytopenia.<sup id="cite_ref-Ahmed_1-6" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Warkentin2006_4-3" class="reference"><a href="#cite_note-Warkentin2006-4"><span>[</span>4<span>]</span></a></sup></p>
<p>Formation of PF4-heparin antibodies is common in people receiving heparin, but only a proportion of these develop thrombocytopenia or thrombosis.<sup id="cite_ref-Ahmed_1-7" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup> This has been referred to as an "iceberg phenomenon".<sup id="cite_ref-KeltonWarkentin_2-1" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit&amp;section=3" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>HIT may be suspected if blood tests show a falling platelet count in someone receiving heparin, even if the heparin has already been discontinued. Professional guidelines recommend that people receiving heparin have a <a href="/wiki/Complete_blood_count" title="Complete blood count">complete blood count</a> (which includes a platelet count) on a regular basis while receiving <a href="/wiki/Heparin" title="Heparin">heparin</a>.<sup id="cite_ref-Hirsh_3-1" class="reference"><a href="#cite_note-Hirsh-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-Keeling_6-0" class="reference"><a href="#cite_note-Keeling-6"><span>[</span>6<span>]</span></a></sup></p>
<p>However, not all people with a falling platelet count while receiving heparin turn out to have HIT. The timing, severity of the thrombocytopenia, the occurrence of new thrombosis, and the presence of alternative explanations, all determine the likelihood that HIT is present. A commonly used score to predict the likelihood of HIT is the "4 Ts" score introduced in 2003.<sup id="cite_ref-4Toriginal_7-0" class="reference"><a href="#cite_note-4Toriginal-7"><span>[</span>7<span>]</span></a></sup> A score of 0–8 points is generated; if the score is 0-3, HIT is unlikely. A score of 4–5 indicates intermediate probability, while a score of 6–8 makes it highly likely. Those with a high score may need to be treated with an alternative drug while more sensitive and specific tests for HIT are performed, while those with a low score can safely continue receiving heparin as the likelihood that they have HIT is extremely low.<sup id="cite_ref-Ahmed_1-8" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Warkentin2006_4-4" class="reference"><a href="#cite_note-Warkentin2006-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Warkentin2003_8-0" class="reference"><a href="#cite_note-Warkentin2003-8"><span>[</span>8<span>]</span></a></sup> In an analysis of the reliability of the 4T score, a low score had a <a href="/wiki/Negative_predictive_value" title="Negative predictive value" class="mw-redirect">negative predictive value</a> of 0.998, while an intermediate score had a <a href="/wiki/Positive_predictive_value" title="Positive predictive value" class="mw-redirect">positive predictive value</a> of 0.14 and a high score a positive predictive value of 0.64; intermediate and high scores therefore warrant further investigation.<sup id="cite_ref-Cuker2012_9-0" class="reference"><a href="#cite_note-Cuker2012-9"><span>[</span>9<span>]</span></a></sup></p>
<table class="wikitable" style="margin-left:15px; text-align:center">
<tr>
<th width="20%">Element</th>
<th>The 4T score for heparin-induced thrombocytopenia<sup id="cite_ref-Keeling_6-1" class="reference"><a href="#cite_note-Keeling-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-4Toriginal_7-1" class="reference"><a href="#cite_note-4Toriginal-7"><span>[</span>7<span>]</span></a></sup></th>
</tr>
<tr>
<th>Thrombocytopenia</th>
<td align="left">2 points if the fall in platelet count is &gt;50% of the previous value, or the lowest count (nadir) is 20–100&#160;×&#160;10<sup>9</sup>/liter<br />
1 point if the fall is 30–50% or the nadir is 10–19&#160;×&#160;10<sup>9</sup>/liter<br />
No points if the fall is less than 30% or the nadir is &lt;10&#160;×&#160;10<sup>9</sup>/liter.</td>
</tr>
<tr>
<th>Timing</th>
<td align="left">2 points if the fall is between days 5–10 after commencement of treatment<br />
1 point if the fall is after day 10. If someone has been exposed to heparin within the last 30 days and then has a drop in platelet count within a day of reexposure, 2 points are given. If the previous exposure was 30–100 days ago, 1 point<br />
If the fall is early but there has been no previous heparin exposure, no points.</td>
</tr>
<tr>
<th>Thrombosis</th>
<td align="left">2 points in new proven thrombosis, skin necrosis (see below), or systemic reaction<br />
1 point if progressive or recurrent thrombosis, silent thrombosis or red skin lesions<br />
No points if there are no symptoms.</td>
</tr>
<tr>
<th>Alternative cause possible</th>
<td align="left">2 points if no other cause<br />
1 point if there is a possible alternative cause<br />
No points if there is a definite alternative cause.</td>
</tr>
</table>
<p>The first screening test in someone suspected of having HIT is aimed at detecting antibodies against heparin-PF4 complexes. This may be with a laboratory test of the <a href="/wiki/ELISA" title="ELISA">ELISA</a> (enzyme-linked immunosorbent assay) type. The ELISA test, however, detects all circulating antibodies that bind heparin-PF4 complexes, and may also <a href="/wiki/Type_I_and_type_II_errors" title="Type I and type II errors">falsely identify</a> antibodies that do not cause HIT. Therefore, those with a positive ELISA are tested further with a functional assay. This test uses platelets and serum from the patient; the platelets are washed and mixed with serum and heparin. The sample is then tested for the release of <a href="/wiki/Serotonin" title="Serotonin">serotonin</a>, a marker of platelet activation. If this serotonin release assay (SRA) shows high serotonin release, the diagnosis of HIT is confirmed. The SRA test is difficult to perform and is usually only done in regional laboratories.<sup id="cite_ref-Ahmed_1-9" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Warkentin2006_4-5" class="reference"><a href="#cite_note-Warkentin2006-4"><span>[</span>4<span>]</span></a></sup></p>
<p>If someone has been diagnosed with HIT, some recommend routine <a href="/wiki/Medical_ultrasonography#Doppler_ultrasonography" title="Medical ultrasonography" class="mw-redirect">Doppler sonography</a> of the leg veins to identify deep vein thromboses, as this is very common in HIT.<sup id="cite_ref-Warkentin2006_4-6" class="reference"><a href="#cite_note-Warkentin2006-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Warkentin2003_8-1" class="reference"><a href="#cite_note-Warkentin2003-8"><span>[</span>8<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit&amp;section=4" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Argatroban.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Argatroban.svg/220px-Argatroban.svg.png" width="220" height="160" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Argatroban.svg/330px-Argatroban.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Argatroban.svg/440px-Argatroban.svg.png 2x" data-file-width="1515" data-file-height="1100" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Argatroban.svg" class="internal" title="Enlarge"></a></div>
Molecular structure of argatroban, a <a href="/wiki/Direct_thrombin_inhibitor" title="Direct thrombin inhibitor">direct thrombin inhibitor</a> used as an alternative to heparin in HIT.</div>
</div>
</div>
<p>Given the fact that HIT predisposes strongly to new episodes of thrombosis, it is not sufficient to simply discontinue the heparin administration. Generally, an alternative anticoagulant is needed to suppress the thrombotic tendency while the generation of antibodies stops and the platelet count recovers. To make matters more complicated, the other most commonly used anticoagulant, <a href="/wiki/Warfarin" title="Warfarin">warfarin</a>, should not be used in HIT until the platelet count is at least 150 x 10^9/L because there is a very high risk of <a href="/wiki/Warfarin_necrosis" title="Warfarin necrosis">warfarin necrosis</a> in people with HIT who have low platelet counts. Warfarin necrosis is the development of skin gangrene in those receiving warfarin or a similar <a href="/wiki/Vitamin_K_antagonist" title="Vitamin K antagonist">vitamin K inhibitor</a>. If the patient was receiving warfarin at the time when HIT is diagnosed, the activity of warfarin is reversed with <a href="/wiki/Vitamin_K" title="Vitamin K">vitamin K</a>.<sup id="cite_ref-Ahmed_1-10" class="reference"><a href="#cite_note-Ahmed-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Keeling_6-2" class="reference"><a href="#cite_note-Keeling-6"><span>[</span>6<span>]</span></a></sup> Transfusing platelets is discouraged, as there is a theoretical risk that this may worsen the risk of thrombosis; the platelet count is rarely low enough to be the principal cause of significant hemorrhage.<sup id="cite_ref-Keeling_6-3" class="reference"><a href="#cite_note-Keeling-6"><span>[</span>6<span>]</span></a></sup></p>
<p>Three agents are used to provide anticoagulation in those with strongly suspected or proven HIT: <a href="/wiki/Danaparoid" title="Danaparoid">danaparoid</a>, <a href="/wiki/Lepirudin" title="Lepirudin">lepirudin</a>, and <a href="/wiki/Argatroban" title="Argatroban">argatroban</a>. These are alternatives to heparin therapy. Not all agents are registered in all countries. For instance, argatroban is only recently licensed in the United Kingdom, and danaparoid is not available in the United States.<sup id="cite_ref-WarkentinMakris_5-1" class="reference"><a href="#cite_note-WarkentinMakris-5"><span>[</span>5<span>]</span></a></sup> Lepirudin production stopped on May 31, 2012.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2013)">citation needed</span></a></i>]</sup> A fourth agent known as <a href="/wiki/Fondaparinux" title="Fondaparinux">fondaparinux</a> acts as a Factor Xa inhibitor and is commonly used off label for HIT treatment in the United States.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (February 2013)">citation needed</span></a></i>]</sup></p>
<p>According to a <a href="/wiki/Systematic_review" title="Systematic review">systematic review</a>, people with HIT treated with <a href="/wiki/Lepirudin" title="Lepirudin">lepirudin</a> showed a <a href="/wiki/Relative_risk_reduction" title="Relative risk reduction">relative risk reduction</a> of clinical outcome (death, amputation, etc.) to be 0.52 and 0.42 when compared to patient controls. In addition, people treated with <a href="/wiki/Argatroban" title="Argatroban">argatroban</a> for HIT showed a <a href="/wiki/Relative_risk_reduction" title="Relative risk reduction">relative risk reduction</a> of the above clinical outcomes to be 0.20 and 0.18.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit&amp;section=5" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The exact number of cases of HIT in the general population is unknown. What is known is that women receiving heparin after a recent surgical procedure, particularly <a href="/wiki/Cardiothoracic_surgery" title="Cardiothoracic surgery">cardiothoracic surgery</a>, have a higher risk, while the risk is very low in women just before and after giving birth. Some studies have shown that HIT is less common in those receiving low molecular weight heparin.<sup id="cite_ref-Warkentin2006_4-7" class="reference"><a href="#cite_note-Warkentin2006-4"><span>[</span>4<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit&amp;section=6" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>While heparin was introduced for clinical use in the late 1930s, new thrombosis in people treated with heparin was not described until 1957, when vascular surgeons reported the association.<sup id="cite_ref-KeltonWarkentin_2-2" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup> The fact that this phenomenon occurred together with thrombocytopenia was reported in 1969;<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> prior to this time, platelet counts were not routinely performed.<sup id="cite_ref-KeltonWarkentin_2-3" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup> A 1973 report established HIT as a diagnosis, as well as suggesting that its features were the result of an immune process.<sup id="cite_ref-KeltonWarkentin_2-4" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup></p>
<p>Initially, various theories existed about the exact cause of the low platelets in HIT. Gradually, evidence accumulated on the exact underlying mechanism.<sup id="cite_ref-KeltonWarkentin_2-5" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup> In 1984-1986, <a href="/wiki/John_G._Kelton" title="John G. Kelton">John G. Kelton</a> and colleagues of <a href="/wiki/McMaster_University" title="McMaster University">McMaster University</a> developed the laboratory tests that could be used to confirm or exclude heparin-induced thrombocytopenia.<sup id="cite_ref-KeltonWarkentin_2-6" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup></p>
<p>Treatment was initially limited to aspirin and warfarin, but the 1990s saw the introduction of a number of agents that could provide anticoagulation without a risk of recurrent HIT.<sup id="cite_ref-KeltonWarkentin_2-7" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup> Older terminology distinguishes between two forms of heparin-induced thrombocytopenia: type 1 (mild, non-immune mediated and self-limiting fall in platelet count) and type 2, the form described above. Currently, the term HIT is used without a modifier to describe the immune-mediated severe form.<sup id="cite_ref-KeltonWarkentin_2-8" class="reference"><a href="#cite_note-KeltonWarkentin-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit&amp;section=7" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Ahmed-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ahmed_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ahmed_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ahmed_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Ahmed_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Ahmed_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Ahmed_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Ahmed_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Ahmed_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Ahmed_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Ahmed_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Ahmed_1-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ahmed I, Majeed A, Powell R (September 2007). <a rel="nofollow" class="external text" href="http://pmj.bmj.com/cgi/content/full/83/983/575">"Heparin induced thrombocytopenia: diagnosis and management update"</a>. <i>Postgrad Med J</i> <b>83</b> (983): 575–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fpgmj.2007.059188">10.1136/pgmj.2007.059188</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2600013">2600013</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17823223">17823223</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Heparin+induced+thrombocytopenia%3A+diagnosis+and+management+update&amp;rft.au=Ahmed+I%2C+Majeed+A%2C+Powell+R&amp;rft.aulast=Ahmed+I%2C+Majeed+A%2C+Powell+R&amp;rft.date=September+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fpmj.bmj.com%2Fcgi%2Fcontent%2Ffull%2F83%2F983%2F575&amp;rft_id=info%3Adoi%2F10.1136%2Fpgmj.2007.059188&amp;rft_id=info%3Apmc%2F2600013&amp;rft_id=info%3Apmid%2F17823223&amp;rft.issue=983&amp;rft.jtitle=Postgrad+Med+J&amp;rft.pages=575-82&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=83" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-KeltonWarkentin-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-KeltonWarkentin_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-KeltonWarkentin_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-KeltonWarkentin_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-KeltonWarkentin_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-KeltonWarkentin_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-KeltonWarkentin_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-KeltonWarkentin_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-KeltonWarkentin_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-KeltonWarkentin_2-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Kelton JG, Warkentin TE (October 2008). <a rel="nofollow" class="external text" href="http://bloodjournal.hematologylibrary.org/cgi/content/full/112/7/2607">"Heparin-induced thrombocytopenia: a historical perspective"</a>. <i>Blood</i> <b>112</b> (7): 2607–16. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2008-02-078014">10.1182/blood-2008-02-078014</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18809774">18809774</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Heparin-induced+thrombocytopenia%3A+a+historical+perspective&amp;rft.au=Kelton+JG%2C+Warkentin+TE&amp;rft.aulast=Kelton+JG%2C+Warkentin+TE&amp;rft.date=October+2008&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcgi%2Fcontent%2Ffull%2F112%2F7%2F2607&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2008-02-078014&amp;rft_id=info%3Apmid%2F18809774&amp;rft.issue=7&amp;rft.jtitle=Blood&amp;rft.pages=2607-16&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=112" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hirsh-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hirsh_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hirsh_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI (June 2008). "Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)". <i>Chest</i> <b>133</b> (6 Suppl): 141S–159S. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.08-0689">10.1378/chest.08-0689</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18574264">18574264</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Parenteral+anticoagulants%3A+American+College+of+Chest+Physicians+Evidence-Based+Clinical+Practice+Guidelines+%288th+Edition%29&amp;rft.au=Hirsh+J%2C+Bauer+KA%2C+Donati+MB%2C+Gould+M%2C+Samama+MM%2C+Weitz+JI&amp;rft.aulast=Hirsh+J%2C+Bauer+KA%2C+Donati+MB%2C+Gould+M%2C+Samama+MM%2C+Weitz+JI&amp;rft.date=June+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.08-0689&amp;rft_id=info%3Apmid%2F18574264&amp;rft.issue=6+Suppl&amp;rft.jtitle=Chest&amp;rft.pages=141S-159S&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=133" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Warkentin2006-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Warkentin2006_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Warkentin2006_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Warkentin2006_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Warkentin2006_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Warkentin2006_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Warkentin2006_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Warkentin2006_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Warkentin2006_4-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Warkentin TE (2006). "Think of HIT". <i>Hematology Am Soc Hematol Educ Program</i> <b>2006</b>: 408–14. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fasheducation-2006.1.408">10.1182/asheducation-2006.1.408</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17124091">17124091</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Think+of+HIT&amp;rft.aulast=Warkentin+TE&amp;rft.au=Warkentin+TE&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2006.1.408&amp;rft_id=info%3Apmid%2F17124091&amp;rft.jtitle=Hematology+Am+Soc+Hematol+Educ+Program&amp;rft.pages=408-14&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2006" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WarkentinMakris-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-WarkentinMakris_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WarkentinMakris_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Warkentin TE, Makris M, Jay RM, Kelton JG (2008). "A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia". <i>Am J Med</i> <b>121</b> (7): 632–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.amjmed.2008.03.012">10.1016/j.amjmed.2008.03.012</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18589060">18589060</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=A+spontaneous+prothrombotic+disorder+resembling+heparin-induced+thrombocytopenia&amp;rft.aulast=Warkentin+TE%2C+Makris+M%2C+Jay+RM%2C+Kelton+JG&amp;rft.au=Warkentin+TE%2C+Makris+M%2C+Jay+RM%2C+Kelton+JG&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2008.03.012&amp;rft_id=info%3Apmid%2F18589060&amp;rft.issue=7&amp;rft.jtitle=Am+J+Med&amp;rft.pages=632-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=121" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Keeling-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Keeling_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Keeling_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Keeling_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Keeling_6-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Keeling D, Davidson S, Watson H (May 2006). <a rel="nofollow" class="external text" href="http://www3.interscience.wiley.com/cgi-bin/fulltext/118607806/HTMLSTART">"The management of heparin-induced thrombocytopenia"</a>. <i>Br. J. Haematol.</i> <b>133</b> (3): 259–69. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2141.2006.06018.x">10.1111/j.1365-2141.2006.06018.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16643427">16643427</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=The+management+of+heparin-induced+thrombocytopenia&amp;rft.au=Keeling+D%2C+Davidson+S%2C+Watson+H&amp;rft.aulast=Keeling+D%2C+Davidson+S%2C+Watson+H&amp;rft.date=May+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww3.interscience.wiley.com%2Fcgi-bin%2Ffulltext%2F118607806%2FHTMLSTART&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.2006.06018.x&amp;rft_id=info%3Apmid%2F16643427&amp;rft.issue=3&amp;rft.jtitle=Br.+J.+Haematol.&amp;rft.pages=259-69&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=133" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4Toriginal-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-4Toriginal_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-4Toriginal_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Warkentin TE, Heddle NM (March 2003). "Laboratory diagnosis of immune heparin-induced thrombocytopenia". <i>Curr Hematol Rep</i> <b>2</b> (2): 148–57. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12901146">12901146</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Laboratory+diagnosis+of+immune+heparin-induced+thrombocytopenia&amp;rft.aulast=Warkentin+TE%2C+Heddle+NM&amp;rft.au=Warkentin+TE%2C+Heddle+NM&amp;rft.date=March+2003&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F12901146&amp;rft.issue=2&amp;rft.jtitle=Curr+Hematol+Rep&amp;rft.pages=148-57&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Warkentin2003-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Warkentin2003_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Warkentin2003_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Warkentin TE, Aird WC, Rand JH (2003). <a rel="nofollow" class="external text" href="http://asheducationbook.hematologylibrary.org/cgi/content/full/2003/1/497">"Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome"</a>. <i>Hematology Am Soc Hematol Educ Program</i>: 497–519. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fasheducation-2003.1.497">10.1182/asheducation-2003.1.497</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14633796">14633796</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Platelet-endothelial+interactions%3A+sepsis%2C+HIT%2C+and+antiphospholipid+syndrome&amp;rft.aulast=Warkentin+TE%2C+Aird+WC%2C+Rand+JH&amp;rft.au=Warkentin+TE%2C+Aird+WC%2C+Rand+JH&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fasheducationbook.hematologylibrary.org%2Fcgi%2Fcontent%2Ffull%2F2003%2F1%2F497&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2003.1.497&amp;rft_id=info%3Apmid%2F14633796&amp;rft.jtitle=Hematology+Am+Soc+Hematol+Educ+Program&amp;rft.pages=497-519&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Cuker2012-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-Cuker2012_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Cuker A, Gimotty PA, Crowther MA, Warkentin TE (September 2012). <a rel="nofollow" class="external text" href="http://bloodjournal.hematologylibrary.org/content/120/20/4160.full">"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis"</a>. <i>Blood</i> <b>120</b> (20): 4160–4167. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2012-07-443051">10.1182/blood-2012-07-443051</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22990018">22990018</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Predictive+value+of+the+4Ts+scoring+system+for+heparin-induced+thrombocytopenia%3A+a+systematic+review+and+meta-analysis&amp;rft.au=Cuker+A%2C+Gimotty+PA%2C+Crowther+MA%2C+Warkentin+TE&amp;rft.aulast=Cuker+A%2C+Gimotty+PA%2C+Crowther+MA%2C+Warkentin+TE&amp;rft.date=September+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcontent%2F120%2F20%2F4160.full&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2012-07-443051&amp;rft_id=info%3Apmid%2F22990018&amp;rft.issue=20&amp;rft.jtitle=Blood&amp;rft.pages=4160-4167&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=120" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Hirsh J, Heddle N, Kelton J (2004). <a rel="nofollow" class="external text" href="http://archinte.ama-assn.org/cgi/content/full/164/4/361">"Treatment of heparin-induced thrombocytopenia: a critical review"</a>. <i>Arch Intern Med</i> <b>164</b> (4): 361–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchinte.164.4.361">10.1001/archinte.164.4.361</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14980986">14980986</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Treatment+of+heparin-induced+thrombocytopenia%3A+a+critical+review&amp;rft.au=Hirsh+J%2C+Heddle+N%2C+Kelton+J&amp;rft.aulast=Hirsh+J%2C+Heddle+N%2C+Kelton+J&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Farchinte.ama-assn.org%2Fcgi%2Fcontent%2Ffull%2F164%2F4%2F361&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.164.4.361&amp;rft_id=info%3Apmid%2F14980986&amp;rft.issue=4&amp;rft.jtitle=Arch+Intern+Med&amp;rft.pages=361-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=164" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Weismann RE, Tobin RW (February 1958). "Arterial embolism occurring during systemic heparin therapy". <i>AMA Arch Surg</i> <b>76</b> (2): 219–25; discussion 225–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchsurg.1958.01280200041005">10.1001/archsurg.1958.01280200041005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13497418">13497418</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Arterial+embolism+occurring+during+systemic+heparin+therapy&amp;rft.aulast=Weismann+RE%2C+Tobin+RW&amp;rft.au=Weismann+RE%2C+Tobin+RW&amp;rft.date=February+1958&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchsurg.1958.01280200041005&amp;rft_id=info%3Apmid%2F13497418&amp;rft.issue=2&amp;rft.jtitle=AMA+Arch+Surg&amp;rft.pages=219-25%3B+discussion+225-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=76" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Natelson EA, Lynch EC, Alfrey CP, Gross JB (December 1969). "Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy". <i>Ann. Intern. Med.</i> <b>71</b> (6): 1121–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-71-6-1121">10.7326/0003-4819-71-6-1121</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/5391254">5391254</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Heparin-induced+thrombocytopenia.+An+unexpected+response+to+treatment+of+consumption+coagulopathy&amp;rft.aulast=Natelson+EA%2C+Lynch+EC%2C+Alfrey+CP%2C+Gross+JB&amp;rft.au=Natelson+EA%2C+Lynch+EC%2C+Alfrey+CP%2C+Gross+JB&amp;rft.date=December+1969&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-71-6-1121&amp;rft_id=info%3Apmid%2F5391254&amp;rft.issue=6&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.pages=1121-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=71" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Rhodes GR, Dixon RH, Silver D (March 1973). "Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations". <i>Surg Gynecol Obstet</i> <b>136</b> (3): 409–16. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4688805">4688805</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=Heparin+induced+thrombocytopenia+with+thrombotic+and+hemorrhagic+manifestations&amp;rft.aulast=Rhodes+GR%2C+Dixon+RH%2C+Silver+D&amp;rft.au=Rhodes+GR%2C+Dixon+RH%2C+Silver+D&amp;rft.date=March+1973&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F4688805&amp;rft.issue=3&amp;rft.jtitle=Surg+Gynecol+Obstet&amp;rft.pages=409-16&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=136" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Kelton, John; Carter, C; Sheridan, D (1 January 1986). <a rel="nofollow" class="external text" href="http://www.bloodjournal.org/content/67/1/27">"A diagnostic test for heparin-induced thrombocytopenia"</a>. <i>Blood</i> <b>67</b> (1). <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3940551">3940551</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHeparin-induced+thrombocytopenia&amp;rft.atitle=A+diagnostic+test+for+heparin-induced+thrombocytopenia&amp;rft.au=Carter%2C+C&amp;rft.aufirst=John&amp;rft.au=Kelton%2C+John&amp;rft.aulast=Kelton&amp;rft.au=Sheridan%2C+D&amp;rft.date=1+January+1986&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloodjournal.org%2Fcontent%2F67%2F1%2F27&amp;rft_id=info%3Apmid%2F3940551&amp;rft.issue=1&amp;rft.jtitle=Blood&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Diseases_of_RBCs_and_megakaryocytes" title="Template:Diseases of RBCs and megakaryocytes"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Diseases_of_RBCs_and_megakaryocytes" title="Template talk:Diseases of RBCs and megakaryocytes"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Diseases_of_RBCs_and_megakaryocytes&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Hematologic_disease" title="Hematologic disease">Diseases</a> of <a href="/wiki/Red_blood_cell" title="Red blood cell">RBCs</a> and <a href="/wiki/Megakaryocyte" title="Megakaryocyte">megakaryocytes</a> / <a href="/wiki/Megakaryocyte%E2%80%93erythroid_progenitor_cell" title="Megakaryocyte–erythroid progenitor cell">MEP</a> (<a href="/wiki/ICD-10_Chapter_III:_Diseases_of_the_blood_and_blood-forming_organs,_and_certain_disorders_involving_the_immune_mechanism#D50-D89_-_Diseases_of_the_blood_and_blood-forming_organs_and_certain_disorders_involving_the_immune_mechanism" title="ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism">D50–69,74</a>, <a href="/wiki/List_of_ICD-9_codes_280%E2%80%93289:_diseases_of_the_blood_and_blood-forming_organs" title="List of ICD-9 codes 280–289: diseases of the blood and blood-forming organs">280–287</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Red_blood_cell" title="Red blood cell">Red<br />
blood cells</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">↑</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Polycythemia" title="Polycythemia">Polycythemia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Polycythemia_vera" title="Polycythemia vera">Polycythemia vera</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">↓</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Anemia" title="Anemia">Anemia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Nutritional_anemia" title="Nutritional anemia">Nutritional</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Microcytic_anemia" title="Microcytic anemia">Micro-</a>: <a href="/wiki/Iron-deficiency_anemia" title="Iron-deficiency anemia">Iron-deficiency anemia</a>
<ul>
<li><a href="/wiki/Plummer%E2%80%93Vinson_syndrome" title="Plummer–Vinson syndrome">Plummer–Vinson syndrome</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Macrocytic_anemia" title="Macrocytic anemia">Macro-</a>: <a href="/wiki/Megaloblastic_anemia" title="Megaloblastic anemia">Megaloblastic anemia</a>
<ul>
<li><a href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hemolytic_anemia" title="Hemolytic anemia">Hemolytic</a><br />
(mostly <a href="/wiki/Normocytic_anemia" title="Normocytic anemia">normo-</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Congenital_hemolytic_anemia" title="Congenital hemolytic anemia">Hereditary</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Enzymopathy" title="Enzymopathy" class="mw-redirect">enzymopathy</a>:</i> <a href="/wiki/Glucose-6-phosphate_dehydrogenase_deficiency" title="Glucose-6-phosphate dehydrogenase deficiency">G6PD</a></li>
<li><i><a href="/wiki/Glycolysis" title="Glycolysis">glycolysis</a></i>
<ul>
<li><a href="/wiki/Pyruvate_kinase_deficiency" title="Pyruvate kinase deficiency">PK</a></li>
<li><a href="/wiki/Triosephosphate_isomerase_deficiency" title="Triosephosphate isomerase deficiency">TI</a></li>
<li><a href="/wiki/Hexokinase_deficiency" title="Hexokinase deficiency">HK</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Hemoglobinopathy" title="Hemoglobinopathy">hemoglobinopathy</a>:</i> <a href="/wiki/Thalassemia" title="Thalassemia">Thalassemia</a>
<ul>
<li><a href="/wiki/Alpha-thalassemia" title="Alpha-thalassemia">alpha</a></li>
<li><a href="/wiki/Beta-thalassemia" title="Beta-thalassemia" class="mw-redirect">beta</a></li>
<li><a href="/wiki/Delta-thalassemia" title="Delta-thalassemia">delta</a></li>
</ul>
</li>
<li><a href="/wiki/Sickle-cell_disease" title="Sickle-cell disease">Sickle-cell disease</a>/<a href="/wiki/Sickle_cell_trait" title="Sickle cell trait">trait</a></li>
<li><a href="/wiki/Hereditary_persistence_of_fetal_hemoglobin" title="Hereditary persistence of fetal hemoglobin">HPFH</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Red_blood_cell#Membranes_and_surface_proteins" title="Red blood cell">membrane</a>:</i> <a href="/wiki/Hereditary_spherocytosis" title="Hereditary spherocytosis">Hereditary spherocytosis</a>
<ul>
<li><a href="/wiki/Minkowski%E2%80%93Chauffard_syndrome" title="Minkowski–Chauffard syndrome" class="mw-redirect">Minkowski–Chauffard syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Hereditary_elliptocytosis" title="Hereditary elliptocytosis">Hereditary elliptocytosis</a>
<ul>
<li><a href="/wiki/Southeast_Asian_ovalocytosis" title="Southeast Asian ovalocytosis">Southeast Asian ovalocytosis</a></li>
</ul>
</li>
<li><a href="/wiki/Hereditary_stomatocytosis" title="Hereditary stomatocytosis">Hereditary stomatocytosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Acquired_hemolytic_anemia" title="Acquired hemolytic anemia">Acquired</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune</a>
<ul>
<li><a href="/wiki/Warm_autoimmune_hemolytic_anemia" title="Warm autoimmune hemolytic anemia">WAHA</a></li>
<li><a href="/wiki/Cold_agglutinin_disease" title="Cold agglutinin disease">CAD</a></li>
<li><a href="/wiki/Paroxysmal_cold_hemoglobinuria" title="Paroxysmal cold hemoglobinuria">PCH</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Red_blood_cell#Membranes_and_surface_proteins" title="Red blood cell">membrane</a></i>
<ul>
<li><a href="/wiki/Paroxysmal_nocturnal_hemoglobinuria" title="Paroxysmal nocturnal hemoglobinuria">PNH</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Microangiopathic_hemolytic_anemia" title="Microangiopathic hemolytic anemia">MAHA</a></li>
<li><a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">TM</a>
<ul>
<li><a href="/wiki/Hemolytic-uremic_syndrome" title="Hemolytic-uremic syndrome">HUS</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Drug-induced_autoimmune_hemolytic_anemia" title="Drug-induced autoimmune hemolytic anemia">Drug-induced autoimmune</a></li>
<li><a href="/wiki/Drug-induced_nonautoimmune_hemolytic_anemia" title="Drug-induced nonautoimmune hemolytic anemia">Drug-induced nonautoimmune</a></li>
</ul>
<ul>
<li><a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Aplastic_anemia" title="Aplastic anemia">Aplastic</a><br />
(mostly <a href="/wiki/Normocytic_anemia" title="Normocytic anemia">normo-</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Congenital_hypoplastic_anemia" title="Congenital hypoplastic anemia">Hereditary</a>: <a href="/wiki/Fanconi_anemia" title="Fanconi anemia">Fanconi anemia</a></li>
<li><a href="/wiki/Diamond%E2%80%93Blackfan_anemia" title="Diamond–Blackfan anemia">Diamond–Blackfan anemia</a></li>
</ul>
<ul>
<li>Acquired: <a href="/wiki/Pure_red_cell_aplasia" title="Pure red cell aplasia">PRCA</a></li>
<li><a href="/wiki/Sideroblastic_anemia" title="Sideroblastic anemia">Sideroblastic anemia</a></li>
<li><a href="/wiki/Myelophthisic_anemia" title="Myelophthisic anemia">Myelophthisic</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Red_blood_cell_indices" title="Red blood cell indices">Blood tests</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Mean_corpuscular_volume" title="Mean corpuscular volume">MCV</a></i>
<ul>
<li><a href="/wiki/Normocytic_anemia" title="Normocytic anemia">Normocytic</a></li>
<li><a href="/wiki/Microcytic_anemia" title="Microcytic anemia">Microcytic</a></li>
<li><a href="/wiki/Macrocytic_anemia" title="Macrocytic anemia">Macrocytic</a></li>
</ul>
</li>
<li><i><a href="/wiki/Mean_corpuscular_hemoglobin_concentration" title="Mean corpuscular hemoglobin concentration">MCHC</a></i>
<ul>
<li><a href="/wiki/Normochromic_anemia" title="Normochromic anemia">Normochromic</a></li>
<li><a href="/wiki/Hypochromic_anemia" title="Hypochromic anemia">Hypochromic</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Methemoglobinemia" title="Methemoglobinemia">Methemoglobinemia</a></li>
<li><a href="/wiki/Sulfhemoglobinemia" title="Sulfhemoglobinemia">Sulfhemoglobinemia</a></li>
<li><a href="/wiki/Reticulocytopenia" title="Reticulocytopenia">Reticulocytopenia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Coagulation" title="Coagulation">Coagulation</a>/<br />
<a href="/wiki/Coagulopathy" title="Coagulopathy">coagulopathy</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">↑</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Thrombophilia" title="Thrombophilia">Hyper-<br />
coagulability</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>primary:</i> <a href="/wiki/Antithrombin_III_deficiency" title="Antithrombin III deficiency">Antithrombin III deficiency</a></li>
<li><a href="/wiki/Protein_C_deficiency" title="Protein C deficiency">Protein C deficiency</a>/<a href="/wiki/Activated_protein_C_resistance" title="Activated protein C resistance">Activated protein C resistance</a>/<a href="/wiki/Protein_S_deficiency" title="Protein S deficiency">Protein S deficiency</a>/<a href="/wiki/Factor_V_Leiden" title="Factor V Leiden">Factor V Leiden</a></li>
<li><a href="/wiki/Prothrombin_G20210A" title="Prothrombin G20210A">Prothrombin G20210A</a></li>
<li><a href="/wiki/Sticky_platelet_syndrome" title="Sticky platelet syndrome">Sticky platelet syndrome</a></li>
</ul>
<ul>
<li><i>acquired:</i><a href="/wiki/Thrombocytosis" title="Thrombocytosis">Thrombocytosis</a>
<ul>
<li><a href="/wiki/Essential_thrombocythaemia" title="Essential thrombocythaemia">essential</a></li>
</ul>
</li>
<li><a href="/wiki/Disseminated_intravascular_coagulation" title="Disseminated intravascular coagulation">DIC</a>
<ul>
<li><a href="/wiki/Congenital_afibrinogenemia" title="Congenital afibrinogenemia">Congenital afibrinogenemia</a></li>
<li><a href="/wiki/Purpura_fulminans" title="Purpura fulminans">Purpura fulminans</a></li>
</ul>
</li>
<li><i><a href="/wiki/Autoimmune" title="Autoimmune" class="mw-redirect">autoimmune</a></i>
<ul>
<li><a href="/wiki/Antiphospholipid_syndrome" title="Antiphospholipid syndrome">Antiphospholipid</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">↓</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Bleeding_diathesis" title="Bleeding diathesis">Hypo-<br />
coagulability</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">Thrombocytopenia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Thrombocytopenic_purpura" title="Thrombocytopenic purpura">Thrombocytopenic purpura</a>: <a href="/wiki/Idiopathic_thrombocytopenic_purpura" title="Idiopathic thrombocytopenic purpura">ITP</a>
<ul>
<li><a href="/wiki/Evans_syndrome" title="Evans syndrome">Evans syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">TM</a>
<ul>
<li><a href="/wiki/Thrombotic_thrombocytopenic_purpura" title="Thrombotic thrombocytopenic purpura">TTP</a></li>
<li><a href="/wiki/Upshaw_Schulman_syndrome" title="Upshaw Schulman syndrome" class="mw-redirect">Upshaw Schulman syndrome</a></li>
</ul>
</li>
</ul>
<ul>
<li><strong class="selflink">Heparin-induced thrombocytopenia</strong></li>
<li><a href="/wiki/May%E2%80%93Hegglin_anomaly" title="May–Hegglin anomaly">May–Hegglin anomaly</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Platelet#Diseases" title="Platelet">Platelet function</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>adhesion</i>
<ul>
<li><a href="/wiki/Bernard%E2%80%93Soulier_syndrome" title="Bernard–Soulier syndrome">Bernard–Soulier syndrome</a></li>
</ul>
</li>
<li><i>aggregation</i>
<ul>
<li><a href="/wiki/Glanzmann%27s_thrombasthenia" title="Glanzmann's thrombasthenia">Glanzmann's thrombasthenia</a></li>
</ul>
</li>
<li><i><a href="/wiki/Platelet_storage_pool_deficiency" title="Platelet storage pool deficiency">platelet storage pool deficiency</a></i>
<ul>
<li><a href="/wiki/Hermansky%E2%80%93Pudlak_syndrome" title="Hermansky–Pudlak syndrome">Hermansky–Pudlak syndrome</a></li>
<li><a href="/wiki/Gray_platelet_syndrome" title="Gray platelet syndrome">Gray platelet syndrome</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Clotting_factor" title="Clotting factor" class="mw-redirect">Clotting factor</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Haemophilia" title="Haemophilia">Hemophilia</a>
<ul>
<li><a href="/wiki/Haemophilia_A" title="Haemophilia A">A/VIII</a></li>
<li><a href="/wiki/Haemophilia_B" title="Haemophilia B">B/IX</a></li>
<li><a href="/wiki/Haemophilia_C" title="Haemophilia C">C/XI</a></li>
</ul>
</li>
<li><a href="/wiki/Von_Willebrand_disease" title="Von Willebrand disease">von Willebrand disease</a></li>
<li><a href="/wiki/Hypoprothrombinemia" title="Hypoprothrombinemia">Hypoprothrombinemia/II</a></li>
<li><a href="/wiki/Factor_XIII_deficiency" title="Factor XIII deficiency">XIII</a></li>
<li><a href="/wiki/Dysfibrinogenemia" title="Dysfibrinogenemia">Dysfibrinogenemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Myeloid_navs" title="Template:Myeloid navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Myeloid_navs" title="Template talk:Myeloid navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Myeloid_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Myeloid" title="Myeloid">cells from bone marrow</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Myeloid_innate_immune_system" title="Template:Myeloid innate immune system">Immune system</a></li>
<li><a href="/wiki/Template:Myeloid_blood_cells_and_plasma" title="Template:Myeloid blood cells and plasma">Cells</a></li>
<li><a href="/wiki/Template:Myeloid_physiology" title="Template:Myeloid physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Coagulation" title="Template:Coagulation">coagulation</a></li>
<li><a href="/wiki/Template:Hemeproteins" title="Template:Hemeproteins">proteins</a></li>
<li><a href="/wiki/Template:Granule_contents" title="Template:Granule contents">granule contents</a></li>
<li><a href="/wiki/Template:Colony-stimulating_factors" title="Template:Colony-stimulating factors">colony-stimulating</a></li>
<li>heme and porphyrin
<ul>
<li><i><a href="/wiki/Template:Porphyrin_metabolism_enzymes" title="Template:Porphyrin metabolism enzymes">metabolism</a></i></li>
<li><i><a href="/wiki/Template:Heme_metabolism_intermediates" title="Template:Heme metabolism intermediates">intermediates</a></i></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Diseases_of_RBCs_and_megakaryocytes" title="Template:Diseases of RBCs and megakaryocytes">Red blood cell</a></li>
<li><a href="/wiki/Template:Monocyte_and_granulocyte_disease" title="Template:Monocyte and granulocyte disease">Monocyte and granulocyte</a></li>
<li><a href="/wiki/Template:Myeloid_malignancy" title="Template:Myeloid malignancy">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Histiocytosis" title="Template:Histiocytosis">Histiocytosis</a></li>
<li><a href="/wiki/Template:Cardiovascular_system_symptoms_and_signs" title="Template:Cardiovascular system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_hematology" title="Template:Eponymous medical signs for hematology">eponymous</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Myeloid_blood_tests" title="Template:Myeloid blood tests">Blood tests</a>
<ul>
<li><a href="/wiki/Template:Abnormal_clinical_and_laboratory_findings_for_blood" title="Template:Abnormal clinical and laboratory findings for blood">findings</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Transfusion_medicine" title="Template:Transfusion medicine">Transfusion</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antithrombotics" title="Template:Antithrombotics">thrombosis</a></li>
<li><a href="/wiki/Template:Antihemorrhagics" title="Template:Antihemorrhagics">bleeding</a></li>
<li><a href="/wiki/Template:B03,_B05,_B06" title="Template:B03, B05, B06">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1258
CPU time usage: 0.323 seconds
Real time usage: 0.393 seconds
Preprocessor visited node count: 2068/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 137126/2097152 bytes
Template argument size: 1587/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 1/500
Lua time usage: 0.107/10.000 seconds
Lua memory usage: 3.56 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  320.770      1 - -total
 33.31%  106.840     11 - Template:Navbox
 28.54%   91.535      1 - Template:Reflist
 21.93%   70.357      1 - Template:Infobox_Disease
 18.71%   60.007     14 - Template:Cite_journal
 18.41%   59.047      1 - Template:Infobox
 15.75%   50.511      1 - Template:Myeloid_hematologic_disease
 12.69%   40.714      2 - Template:Citation_needed
 10.62%   34.075      2 - Template:Fix
  9.92%   31.829      5 - Template:Category_handler
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:1056911-0!*!0!!en!4!* and timestamp 20150706172648 and revision id 667652470
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Heparin-induced_thrombocytopenia&amp;oldid=667652470">https://en.wikipedia.org/w/index.php?title=Heparin-induced_thrombocytopenia&amp;oldid=667652470</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Coagulopathies" title="Category:Coagulopathies">Coagulopathies</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_February_2013" title="Category:Articles with unsourced statements from February 2013">Articles with unsourced statements from February 2013</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Heparin-induced+thrombocytopenia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Heparin-induced+thrombocytopenia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Heparin-induced_thrombocytopenia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Heparin-induced_thrombocytopenia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Heparin-induced_thrombocytopenia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Heparin-induced_thrombocytopenia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Heparin-induced_thrombocytopenia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;oldid=667652470" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1598365" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Heparin-induced_thrombocytopenia&amp;id=667652470" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Heparin-induced+thrombocytopenia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Heparin-induced+thrombocytopenia&amp;oldid=667652470&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Heparin-induced_thrombocytopenia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%82%D9%84%D8%A9_%D8%A7%D9%84%D8%B5%D9%81%D9%8A%D8%AD%D8%A7%D8%AA_%D8%A7%D9%84%D9%85%D8%AD%D8%AF%D8%AB%D8%A9_%D8%A8%D8%A7%D9%84%D9%87%D9%8A%D8%A8%D8%A7%D8%B1%D9%8A%D9%86" title="قلة الصفيحات المحدثة بالهيبارين – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Trombocitop%C3%A8nia_indu%C3%AFda_per_heparina" title="Trombocitopènia induïda per heparina – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Heparin-induzierte_Thrombozytopenie" title="Heparin-induzierte Thrombozytopenie – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Thrombop%C3%A9nie_induite_par_l%27h%C3%A9parine" title="Thrombopénie induite par l'héparine – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Trombocitopenia_indotta_da_eparina" title="Trombocitopenia indotta da eparina – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Ma%C5%82op%C5%82ytkowo%C5%9B%C4%87_poheparynowa" title="Małopłytkowość poheparynowa – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%93%D0%B5%D0%BF%D0%B0%D1%80%D0%B8%D0%BD-%D0%B8%D0%BD%D0%B4%D1%83%D1%86%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D0%BD%D0%BD%D0%B0%D1%8F_%D1%82%D1%80%D0%BE%D0%BC%D0%B1%D0%BE%D1%86%D0%B8%D1%82%D0%BE%D0%BF%D0%B5%D0%BD%D0%B8%D1%8F" title="Гепарин-индуцированная тромбоцитопения – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1598365#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 19 June 2015, at 16:59.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Heparin-induced_thrombocytopenia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":129,"wgHostname":"mw1220"});
}</script>
	</body>
</html>
